This session provides a foundational overview of Alzheimer’s disease (AD), tracing its evolution from Alois Alzheimer’s original case description to modern biologically defined frameworks. Participants will examine how conceptualizations of AD have shifted—from a purely clinical syndrome to a continuum defined by underlying pathology—and how this evolution informs current diagnostic criteria and clinical practice.

Breakfast will be served. Seating is limited to 150 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

While Alzheimer’s disease remains the most recognized cause of cognitive decline, clinicians increasingly encounter patients whose symptoms reflect a broader spectrum of neurodegenerative, vascular, and mixed dementias. Accurate differentiation among dementia subtypes is essential for timely diagnosis, management, counseling, and optimization of patient and caregiver outcomes. This session will provide an evidence-based overview of the major dementia syndromes beyond Alzheimer’s disease. Through discussion of clinical presentations, diagnostic considerations, biomarkers, neuroimaging findings, and management strategies, participants will gain practical tools to recognize distinguishing features and navigate the complexities of dementia care across diverse patient populations.

Emerging evidence suggests that modifiable risk factors play a significant role in the development of Alzheimer’s disease. This session explores strategies for risk reduction across the lifespan, from public health interventions to individualized, precision-based approaches incorporating genetics, comorbidities, and lifestyle factors.

Join your peers in the Exhibit Hall to engage and learn about available pharmaceuticals and devices for your practice. Hors d’oeuvres and beverages available.

Breakfast will be served. Seating is limited to 150 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Diagnosis of Alzheimer’s disease is rapidly evolving with the integration of biomarkers into clinical workflows. This session reviews current diagnostic criteria and examines how biomarker confirmation is reshaping early and accurate diagnosis across care settings.

Biomarkers are transforming the diagnosis and management of Alzheimer’s disease. This session provides a comparative overview of cerebrospinal fluid (CSF), PET imaging, and emerging blood-based biomarkers, highlighting their clinical utility, limitations, and future applications.

Disease-modifying therapies represent a paradigm shift in Alzheimer’s care. This session reviews current evidence supporting these therapies, including mechanisms of action, clinical trial data, and real-world considerations such as patient selection, safety monitoring, and health system readiness.

Breakfast will be served. Seating is limited to 150 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of mental health conditions. Both seasoned and early-career mental health professionals will benefit from the knowledge and insights shared by our diverse team of expert clinical faculty. Complementing the overall agenda, these sessions provide a deep dive into emerging therapies, new treatment formulations, and management of the most complex patients, and are designed to answer your most challenging questions. Supported by educational grants and with a focus on translating current research into practical, real-world applications, these sessions will help you effectively integrate the latest advances in mental health care into clinical practice, enhancing your professional skills and improving patient outcomes.

Optimal Alzheimer’s care requires coordination across specialties and care settings. This session highlights the roles of neurologists, psychiatrists, primary care clinicians, nurses, social workers, and caregivers in delivering comprehensive, patient-centered care.

Breakfast will be served. Seating is limited to 150 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Dementia is a progressive condition that requires proactive, longitudinal care planning across clinical, psychosocial, and systems-based domains. This session will equip clinicians with practical strategies to anticipate disease progression, align care with patient and caregiver goals, and coordinate services across the continuum of care. Through a case-informed approach, participants will explore best practices in early and ongoing care planning, including advance care discussions, risk mitigation, behavioral symptom management, caregiver support, and transitions to higher levels of care. Emphasis will be placed on interdisciplinary collaboration among psychiatry, primary care, neurology, and allied health professionals to optimize outcomes and quality of life for patients living with dementia.

Through interactive case discussions, this session synthesizes key concepts across the Alzheimer’s disease continuum. Participants will engage in clinical decision-making around diagnosis, treatment, and management of complex and atypical cases.

Breakfast will be served. Seating is limited to 150 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.

Rapid advances in diagnostics, therapeutics, and care delivery are reshaping the future of Alzheimer’s disease management. This forward-looking session explores emerging innovations, including novel therapeutics, digital tools, and evolving care models.